Avanos Medical (AVNS) Cash from Investing Activities Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -253.01% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -11.91% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -41.67% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -6.88% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -472.46% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -16.93% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -111.03% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | -40.94% |
| 10 | Avanos Medical | 1.17 Bn | 1.10 Bn | 94.20 Mn | -24.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -24.40% |
| Dec 31, 2025 | -11.54% |
| Sep 30, 2025 | -88.54% |
| Jun 30, 2025 | -47.66% |
| Mar 31, 2025 | 57.87% |
| Dec 31, 2024 | -17.37% |
| Sep 30, 2024 | -35.72% |
| Jun 30, 2024 | -0.57% |
| Mar 31, 2024 | 29.47% |
| Dec 31, 2023 | 161.50% |
| Sep 30, 2023 | -91.16% |
| Jun 30, 2023 | 1.97% |
| Mar 31, 2023 | 8.37% |
| Dec 31, 2022 | 15.43% |
| Sep 30, 2022 | 56.63% |
| Jun 30, 2022 | 48.43% |
| Mar 31, 2022 | -113.53% |
| Dec 31, 2021 | 35.85% |
| Sep 30, 2021 | 56.04% |
| Jun 30, 2021 | -26.16% |
| Mar 31, 2021 | 15.95% |
| Dec 31, 2020 | 26.03% |
| Sep 30, 2020 | 20.63% |
| Jun 30, 2020 | -3.08% |
| Mar 31, 2020 | 20.11% |
| Dec 31, 2019 | -24.47% |
| Sep 30, 2019 | -97.30% |
| Jun 30, 2019 | 45.15% |
| Mar 31, 2019 | -16.04% |
| Dec 31, 2018 | -43.69% |
| Sep 30, 2018 | -43.55% |
| Jun 30, 2018 | 251.25% |
| Mar 31, 2018 | 21.70% |
| Dec 31, 2017 | -6.95% |
| Sep 30, 2017 | 24.40% |
| Jun 30, 2017 | 32.52% |
| Mar 31, 2017 | -10.79% |
| Dec 31, 2016 | 27.01% |